← Back to Search

Educational pamphlets for HIV/AIDS

N/A

Waitlist Available

Led By Nwora L Okeke, MD, MPH

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 24 weeks, 48 weeks, 72 weeks

Awards & highlights

Study Summary

This trial will test whether a educational program run by case managers and social workers, delivered over the phone, can help improve outcomes related to cardiovascular disease in HIV-infected patients.

Eligible Conditions

HIV/AIDS
Cardiovascular Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 24 weeks, 48 weeks, 72 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 24 weeks, 48 weeks, 72 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 24 weeks, 48 weeks, 72 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in ambulatory systolic blood pressure

Change in fasting LDL-c levels

Secondary outcome measures

Change in 10-year atherosclerotic cardiovascular disease (ASCVD) risk score

Total weight loss

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Educational pamphlets + telephoneExperimental Treatment2 Interventions

Group II: Educational pamphletsActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Telephone

2018

N/A

~2100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,359 Previous Clinical Trials

3,420,259 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,835 Previous Clinical Trials

47,310,592 Total Patients Enrolled

Nwora L Okeke, MD, MPHPrincipal InvestigatorDuke University

Media Library

Telephone 2023 Treatment Timeline for Medical Study. Trial Name: NCT03839394 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Might I be allowed to partake in this clinical experiment?

"This clinical trial is recruiting 50 individuals aged 40-75 with existing cardiovascular conditions. Aside from age and medical history requirements, potential participants must have a 2013 American Heart Association 10-year ASCVD risk score of 15% or higher, be diagnosed with hypertension or hyperlipidemia, demonstrate the capacity to provide legally binding consent, and have been under care at Duke Infectious Diseases Clinic for HIV over the course of two years."

Answered by AI

Do opportunities remain for individuals to participate in this experiment?

"This study, which was first made available on December 10th 2020, is not currently enrolling patients according to clinicaltrials.gov records. Nevertheless, there are over 650 other trials that are presently seeking participants for their research projects."

Answered by AI

Are elderly individuals eligible to take part in the ongoing research?

"This trial only admits patients within the age bracket of 40 and 75. There are 84 trials that accept minors, while those over 65 can choose from a total 550 clinical studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Case Managers for CVD Risk Reduction in HIV Clinic

2020. "Case Managers for CVD Risk Reduction in HIV Clinic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03839394.